BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18269816)

  • 1. [Long term follow-up results of 199 patients with hypertrophic cardiomyopathy].
    Li M; Wang QB; Cheng K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):988-91. PubMed ID: 18269816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil.
    Arteaga E; Ianni BM; Fernandes F; Mady C
    Am Heart J; 2005 Jun; 149(6):1099-105. PubMed ID: 15976794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A; Williams WG; Choi R; Wigle ED; Rozenblyum E; Fedwick K; Siu S; Ralph-Edwards A; Rakowski H
    Circulation; 2005 Apr; 111(16):2033-41. PubMed ID: 15824202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural history of 82 patients with hypertrophic cardiomyopathy: follow-up for over ten years].
    Ishiwata S; Nishiyama S; Nakanishi S; Nishimura S; Yanagishita Y; Kato K; Seki A; Yamaguchi H
    J Cardiol; 1991; 21(1):61-73. PubMed ID: 1817182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility and safety of exercise testing in patients with hypertrophic cardiomyopathy.
    Olivotto I; Montereggi A; Mazzuoli F; Cecchi F
    G Ital Cardiol; 1999 Jan; 29(1):11-9. PubMed ID: 9987042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Gregori D; Moretti M; Driussi M; Aleksova A; Chersevani D; Sabbadini G; Sinagra G
    Ital Heart J; 2005 Sep; 6(9):721-7. PubMed ID: 16212073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic cardiomyopathy. Long-term clinical development in a regional cohort of 243 patients].
    Gueffet JP; Langlard JM; Burban M; Campion L; Bouhour JB
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):967-74. PubMed ID: 11603071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of left atrial size in predicting adverse clinical events in hypertrophic cardiomyopathy].
    Kahveci G; Bayrak F; Mutlu B; Başaran Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):541-5. PubMed ID: 19223720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy.
    Becker R; Haass M; Ick D; Krueger C; Bauer A; Senges-Becker JC; Voss F; Hilbel T; Niroomand F; Katus HA; Schoels W
    Basic Res Cardiol; 2003 Jul; 98(4):259-66. PubMed ID: 12835955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up.
    Dimitrow PP; Chojnowska L; Rudzinski T; Piotrowski W; Ziólkowska L; Wojtarowicz A; Wycisk A; Dabrowska-Kugacka A; Nowalany-Kozielska E; Sobkowicz B; Wróbel W; Aleszewicz-Baranowska J; Rynkiewicz A; Loboz-Grudzien K; Marchel M; Wysokinski A
    Eur Heart J; 2010 Dec; 31(24):3084-93. PubMed ID: 20843960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.